Discovery Chemistry for
Pharmaceutical Testing

Efficacy entrusted from Molecule to Market.

We support pharmaceutical innovators through every phase of drug development, from molecular discovery to full CMC (Chemistry, Manufacturing & Controls) characterisation. 

Backed by cGMP infrastructure, GLP-compliant practices, and all encompassed analytical instrumentation, we help clients establish data integrity, product quality, and regulatory readiness across the development continuum. 

With deep expertise in small molecules, biologics, and complex formulations, our scientists design and validate processes that are robust, scalable, and compliant with ICH, USP, EP, and FDA expectations. 

407218559 ee4e0f01 8a78 439f b13e be73a5017bdc

Necessity of Discovery Chemistry in Pharmaceutical Testing

Here’s why discovery and CMC testing are indispensable in pharmaceutical development:

  • Ensures Quality by Design

    Establishes critical quality attributes (CQAs) and control strategies from early development, reducing variability and ensuring consistency.

  • Accelerates Regulatory Approvals

    Provides validated scientific data aligned with ICH, FDA, and CDSCO requirements for global submissions.

  • Optimises Formulation Performance

    Identifies the most stable and efficacious formulation through advanced solid-state and excipient compatibility studies.

  • Guarantees Product Stability

    Determines shelf-life and degradation pathways under ICH-compliant conditions, ensuring patient safety and commercial reliability.

  • Supports Tech Transfer & Scale-Up

    Bridges R&D and manufacturing with reproducible, GMP-ready data that ensures seamless product commercialisation.

Areas of Expertise

Specialised & Routine Testing

Specialised & Routine Testing

  • Enzyme activity assays (standardised QC panels) 
  • Heparin potency and purity testing 
  • Low Molecular Weight Heparin (LMWH) assays, including Enoxaparin 
  • Full compliance with USP, EP, and BP specifications 
Delivers precision-driven biochemical and pharmacopeial analyses to ensure product consistency, potency, and therapeutic safety. 

Batch Release & Stability-Indicating Methods

Batch Release & Stability-Indicating Methods

  • Routine QC testing and Certificate of Analysis (CoA) generation 
  • Validation of stability-indicating analytical methods 
Provides reliable release data for commercial batches, ensuring compliance with GMP standards and pharmacopoeial requirements. 

Chiral Analysis & Purification

Chiral Analysis & Purification

  • Enantiomeric purity assessment and resolution 
  • Chiral LC method development and preparative purification 
Supports enantioselective development programs with precision analytical techniques for chiral molecules. 

Analytical & Bioanalytical Chemistry

Analytical & Bioanalytical Chemistry

  • Analytical method development and validation (ICH Q2) 
  • HPLC, UPLC, GC, GC-MS, LC-MS/MS, and CE techniques 
  • Impurity profiling, quantitation, and structural elucidation (qNMR, HR-MS) 
  • Residual solvents and elemental impurities (ICH Q3C / Q3D) 
  • Dissolution, content uniformity, assay, and potency testing 
Delivers validated analytical methods for qualitative and quantitative assessment of APIs and formulations, ensuring data accuracy and regulatory alignment. 

Container/Closure & Stability Studies

Container/Closure & Stability Studies

  • Container–closure compatibility 
  • Extractables and leachables studies for parenteral products 
  • ICH-compliant accelerated and long-term stability studies 
  • Forced degradation studies for stability-indicating methods 
Assures integrity, safety, and performance of drug products throughout their intended shelf life, supporting global regulatory submissions. 

Solid-State & Formulation Science

Solid-State & Formulation Science

  • Salt and polymorph screening 
  • Particle engineering and solid form selection 
  • Pre-formulation and formulation development for oral (IR/MR), parenteral (sterile/lyophilised), inhalation, topical, and transdermal delivery systems 
  • Excipients selection and compatibility evaluation 
Develops stable, bioavailable, and patient-centric dosage forms through a science-driven understanding of physicochemical properties and formulation behaviour. 

API Process Development & Scale-Up

API Process Development & Scale-Up

  • API synthesis, optimisation, and process development 
  • Pilot and GMP-scale API manufacturing 
  • Technology transfer to manufacturing facilities 
Ensures reproducible, high-yield production of APIs with strict impurity and residual solvent control, enabling robust tech transfer from lab to plant. 

Scroll to Top